Search Results - Eron, J.J.

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.

    Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates. by Eron, J J, Gorczyca, P, Kaplan, J C, D'Aquila, R T

    Published 1992
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.

    Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. by Eron, J J, Johnson, V A, Merrill, D P, Chou, T C, Hirsch, M S

    Published 1992
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Maximizing sensitivity and specificity of PCR by pre-amplification heating.

    Maximizing sensitivity and specificity of PCR by pre-amplification heating. by D'Aquila, R T, Bechtel, L J, Videler, J A, Eron, J J, Gorczyca, P, Kaplan, J C

    Published 1991
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase.

    Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase. by Zhang, D, Caliendo, A M, Eron, J J, DeVore, K M, Kaplan, J C, Hirsch, M S, D'Aquila, R T

    Published 1994
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.

    pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo. by Eron, J J, Chow, Y K, Caliendo, A M, Videler, J, Devore, K M, Cooley, T P, Liebman, H A, Kaplan, J C, Hirsch, M S, D'Aquila, R T

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Decreasing Excess Mortality of HIV-infected Patients Initiating Antiretroviral Therapy: Comparison with Mortality in General Population in China, 2003 – 2009

    Decreasing Excess Mortality of HIV-infected Patients Initiating Antiretroviral Therapy: Comparison with Mortality in General Population in China, 2003 – 2009 by ZHU, H., NAPRAVNIK, S., ERON, J.J., COLE, S.R., MA, Y., WOHL, D.A., DOU, Z., ZHANG, Y., LIU, Z., ZHAO, D., YU, L., LIU, X., COHEN, M.S., ZHANG, F.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study

    Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study by Harding, B. N., Whitney, B. M., Nance, R. M., Ruderman, S. A., Crane, H. M., Burkholder, G., Moore, R. D., Mathews, W. C., Eron, J. J., Hunt, P. W., Volberding, P., Rodriguez, B., Mayer, K. H., Saag, M. S., Kitahata, M. M., Heckbert, S. R., Delaney, J. A. C.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Lessons Learned From the Design and Implementation of Myocardial Infarction Adjudication Tailored for HIV Clinical Cohorts

    Lessons Learned From the Design and Implementation of Myocardial Infarction Adjudication Tailored for HIV Clinical Cohorts by Crane, H. M., Heckbert, S. R., Drozd, D. R., Budoff, M. J., Delaney, J. A. C., Rodriguez, C., Paramsothy, P., Lober, W. B., Burkholder, G., Willig, J. H., Mugavero, M. J., Mathews, W. C., Crane, P. K., Moore, R. D., Napravnik, S., Eron, J. J., Hunt, P., Geng, E., Hsue, P., Barnes, G. S., McReynolds, J., Peter, I., Grunfeld, C., Saag, M. S., Kitahata, M. M.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    The Authors Reply

    The Authors Reply by Crane, H. M., Heckbert, S. R., Drozd, D. R., Budoff, M. J., Delaney, J. A. C., Rodriguez, C., Paramsothy, P., Lober, W. B., Burkholder, G., Willig, J. H., Mugavero, M. J., Mathews, W. C., Crane, P. K., Moore, R. D., Napravnik, S., Eron, J. J., Hunt, P., Geng, E., Hsue, P., Barnes, G. S., McReynolds, J., Peter, I., Grunfeld, C., Saag, M. S., Kitahata, M. M.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women by Landovitz, R.J., Donnell, D., Clement, M.E., Hanscom, B., Cottle, L., Coelho, L., Cabello, R., Chariyalertsak, S., Dunne, E.F., Frank, I., Gallardo-Cartagena, J.A., Gaur, A.H., Gonzales, P., Tran, H.V., Hinojosa, J.C., Kallas, E.G., Kelley, C.F., Losso, M.H., Madruga, J.V., Middelkoop, K., Phanuphak, N., Santos, B., Sued, O., Huamaní, J. Valencia, Overton, E.T., Swaminathan, S., del Rio, C., Gulick, R.M., Richardson, P., Sullivan, P., Piwowar-Manning, E., Marzinke, M., Hendrix, C., Li, M., Wang, Z., Marrazzo, J., Daar, E., Asmelash, A., Brown, T.T., Anderson, P., Eshleman, S.H., Bryan, M., Blanchette, C., Lucas, J., Psaros, C., Safren, S., Sugarman, J., Scott, H., Eron, J.J., Fields, S.D., Sista, N.D., Gomez-Feliciano, K., Jennings, A., Kofron, R.M., Holtz, T.H., Shin, K., Rooney, J.F., Smith, K.Y., Spreen, W., Margolis, D., Rinehart, A., Adeyeye, A., Cohen, M.S., McCauley, M., Grinsztejn, B.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: